Premium
Letter: biological therapies are effective for prevention of post‐operative Crohn's disease recurrence
Author(s) -
Bodini G.,
De Cassan C.,
Savarino V.,
Savarino E.
Publication year - 2014
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.12831
Subject(s) - mesalazine , medicine , azathioprine , thiopurine methyltransferase , crohn's disease , adalimumab , infliximab , disease , randomized controlled trial , natural history , surgery , inflammatory bowel disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom